Zavesca

In the US, Zavesca (miglustat systemic) is a member of the drug class miscellaneous metabolic agents and is used to treat Gaucher Disease.

US matches:

• Zavesca

UK matches:

• Zavesca (miglustat) 100 mg hard capsules
• Zavesca (miglustat) 100 mg hard capsules (SPC)

Ingredient matches for Zavesca

Miglustat

Miglustat is reported as an ingredient of Zavesca in the following countries:

• Austria


• Belgium


• Canada


• Czech Republic


• Denmark


• Finland


• France


• Germany


• Hungary


• Ireland


• Israel


• Italy


• Japan


• Luxembourg


• Netherlands


• Norway


• Slovakia


• Slovenia


• Spain


• Sweden


• Switzerland


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.